USD 0.0
(0.0%)
Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|---|
Revenue | - | 9.01 Million | 3.82 Million | 3.01 Million | 1.2 Million | 712.99 Thousand |
Cost of Revenue | - | - | 3.42 Million | 2.4 Million | 712.92 Thousand | 520.49 Thousand |
Gross Profit | - | 9.01 Million | 399.76 Thousand | 613.44 Thousand | 492.73 Thousand | 192.5 Thousand |
Operating Expenses | - | - | 19.54 Million | 12.81 Million | 1.9 Million | 1.12 Million |
Selling, General and Administrative Expenses | - | - | 18.67 Million | 12.44 Million | 1.88 Million | 1.11 Million |
Research and Development Expenses | - | - | 204.7 Thousand | 63.91 Thousand | - | - |
Other Expenses | - | - | 101.95 Thousand | 189.04 Thousand | -20.68 Thousand | -34.15 Thousand |
Cost and Expenses | - | - | 22.96 Million | 15.22 Million | 2.61 Million | 1.64 Million |
Operating Income | - | 9.01 Million | -19.29 Million | -12.28 Million | -1.41 Million | -930.62 Thousand |
Interest Expense | - | - | 41.59 Thousand | 17.88 Thousand | 130.81 Thousand | 278.37 Thousand |
Income Tax Expense | - | - | 143.54 Thousand | 206.93 Thousand | 110.12 Thousand | 244.22 Thousand |
Earnings before Tax | - | - | -37.95 Million | -12.15 Million | -1.56 Million | -1.12 Million |
Net Income | - | - | -37.95 Million | -12.15 Million | -1.56 Million | -1.12 Million |
Earnings Per Share Basic | - | - | -0.38 | -0.12 | -0.01 | -0.01 |
Earnings Per Share Diluted | - | - | -0.38 | -0.12 | -0.01 | -0.01 |
Weighted Average Shares Outstanding | - | - | 99.69 Million | 99.69 Million | 116.69 Million | 116.69 Million |
Weighted Average Shares Outstanding (Diluted) | - | - | 99.69 Million | 99.69 Million | 116.69 Million | 116.69 Million |
Gross Margin | - | 1.00 | 0.10 | 0.20 | 0.41 | 0.27 |
EBIT Margin | - | 1.00 | -4.83 | -4.23 | -1.19 | -1.35 |
Profit Margin | - | - | -9.93 | -4.03 | -1.30 | -1.57 |
EBITDA | - | 9.01 Million | -39.17 Million | -12.09 Million | -1.4 Million | -871.43 Thousand |
Earnings Before Tax Margin | - | 1.00 | -5.05 | -4.07 | -1.17 | -1.31 |
Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - |
Operating Expenses | - | - | - | - | - | - |
Selling, General and Administrative Expenses | - | - | - | - | - | - |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | - | - | - | - | - | - |
Operating Income | - | - | - | - | - | - |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | - | - | - | - | - | - |
Earnings before Tax | - | - | - | - | - | - |
Net Income | - | - | - | - | - | - |
Earnings Per Share Basic | - | - | - | - | - | - |
Earnings Per Share Diluted | - | - | - | - | - | - |
Weighted Average Shares Outstanding | - | - | - | - | - | - |
Weighted Average Shares Outstanding (Diluted) | - | - | - | - | - | - |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - |
Earnings Before Tax Margin | - | - | - | - | - | - |
002329
IPHYF
CVLT
MYOR
VQS
GYRE